Description
OpenEMR before 8.5.0 contains an insecure direct object reference vulnerability in the CAMOS rx_print.php printer that allows authenticated users to read other patients' prescriptions. Attackers can submit forged chrx_ parameters with global prescription IDs to disclose drug names, dosages, directions, and refill counts without medication permissions.
Published: 2026-11-13
Score: 6 Medium
EPSS: < 1% Very Low
KEV: No
Impact: n/a
Action: n/a
AI Analysis

Analysis and contextual insights are available on OpenCVE Cloud.

Remediation

No vendor fix or workaround currently provided.

Additional remediation guidance may be available on OpenCVE Cloud.

Tracking

Sign in to view the affected projects.

Advisories

No advisories yet.

History

Fri, 13 Nov 2026 09:45:00 +0000

Type Values Removed Values Added
Description OpenEMR before 8.5.0 contains an insecure direct object reference vulnerability in the CAMOS rx_print.php printer that allows authenticated users to read other patients' prescriptions. Attackers can submit forged chrx_ parameters with global prescription IDs to disclose drug names, dosages, directions, and refill counts without medication permissions.
Title OpenEMR before 8.5.0 IDOR via CAMOS rx_print.php Prescription Disclosure
First Time appeared Open-emr
Open-emr openemr
Weaknesses CWE-639
CPEs cpe:2.3:a:open-emr:openemr:*:*:*:*:*:*:*:*
Vendors & Products Open-emr
Open-emr openemr
References
Metrics cvssV3_1

{'score': 5.3, 'vector': 'CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:N/A:N'}

cvssV4_0

{'score': 6, 'vector': 'CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N'}


Subscriptions

Open-emr Openemr
cve-icon MITRE

Status: PUBLISHED

Assigner: VulnCheck

Published:

Updated: 2026-11-13T09:35:19.496Z

Reserved: 2026-11-10T21:38:36.342Z

Link: CVE-2026-126441

cve-icon Vulnrichment

No data.

cve-icon NVD

Status : Awaiting Analysis

Published: 2026-11-13T10:17:51.317

Modified: 2026-11-13T10:17:51.437

Link: CVE-2026-126441

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses